To Be your Great HR Partners

¿ì¸®´Â º£Å×¶û ÇìµåÇåÅ͵éÀÔ´Ï´Ù

ä¿ëÁ¤º¸

ä¿ëÆ÷Áö¼Ç : [Á¦¾à ¼Ö·ç¼Ç ±â¾÷] Pharmacovigilance Expert (PVE)

2025-06-02 Á¶È¸¼ö : 23
      • [Á÷¹«]
        * Á¦Ç° ¼ö¸í Áֱ⸦ À§ÇÑ PV Ȱµ¿ °ü¸® ¹× ¼öÇà
        * PV ½Ã½ºÅÛ ¹× ±× ǰÁú ½Ã½ºÅÛ °ü¸®¸¦ À§ÇÑ È°µ¿ ¼öÇà
        * ±¹³» ¹× ±Û·Î¹ú ¶óÀ̼±½º ±Ç¸® À¯Áö¸¦ À§ÇÑ È°µ¿ ¼öÇà
        * ±ÔÁ¦ ´ç±¹°úÀÇ ¼ÒÅë

        [¿ªÇÒ°ú Ã¥ÀÓ]
        * Ç¥ÁØ ¿î¿µ ÀýÂ÷(SOP) ¹× ÇÁ·ÎÁ§Æ®/ÇÁ·Î±×·¥ º° ¾ÈÀü °èȹ¿¡ µû¶ó ICSRÀÇ °ü¸® º¸Àå
        * ǰÁú/ÀÇ·á °ËÅä °á°ú¿¡ µû¸¥ ICSR ½ÂÀÎ
        * ±ÔÁ¦ ´ç±¹¿¡ ½Å¼ÓÇϰí Á¤±âÀûÀ¸·Î º¸°í °ü¸®
        * Á¾ÇÕ ¾ÈÀü º¸°í¼­(DSUR, PSUR/PBRER), À§Çè °ü¸® °èȹ, °»½Å ½ÃÀå ½ÂÀÎ º¸°í¼­ ÀÛ¼º ¹×/¶Ç´Â °ËÅä
        * À§Çè/½ÅÈ£ °ü¸® ÇÁ·Î¼¼½º °¨µ¶
        * ¹®Çå °Ë»ö °ü¸® ¹× °á°ú ½ÂÀÎ
        * PV ±³À° °¨µ¶
        * ±³À° ÀÚ·á, Æò°¡ ¹× °úÁ¤ÀÇ °ËÅä ¹× ½ÂÀÎ
        * PV ¹× ±âŸ ¿äûµÈ SOP/SD¸¦ °³¹ß, ¼öÁ¤ ¹× °ËÅä
        * PV ½Ã½ºÅÛ ¹× ±× ǰÁú ½Ã½ºÅÛ °¨µ¶
        * ¾ÈÀü µ¥ÀÌÅÍ ±³È¯ °è¾à ¿î¿µ ¹× °ËÅä
        * ³»ºÎ ¹× ¿ÜºÎ °¨»ç ¹× °Ë»ç °¨µ¶
        * ¸¶ÄÉÆÃ ÈÄ °¨½Ã ¹× Àç°ËÅä ÇÁ·Î¼¼½º ¿î¿µ ¹× °ü¸®
        * À§Çè ÃÖ¼ÒÈ­ Ȱµ¿ ¹× Ãß°¡ PV Ȱµ¿ °¨µ¶
        * ÀÓ»ó ½ÃÇè °èȹ ´Ü°è¿¡¼­ PV ¹üÀ§ °áÁ¤
        * ÀÓ»ó ½ÃÇè¿¡¼­ SMP¿¡ µû¸¥ PV Ȱµ¿ ¼öÇà ¹×/¶Ç´Â °ü¸®
        * ¾ÈÀü °ü¸® °èȹ ¹× Á¶»ç ¼­·ù °ËÅä ¹× ½ÂÀÎ
        * ¾ÈÀü µ¥ÀÌÅͺ£À̽º °¨µ¶(±Û·Î¹ú ¾ÈÀü µ¥ÀÌÅͺ£À̽º ¹× ICSR ÃßÀû±â) / UAT
        * µ¥ÀÌÅÍ ¾ÈÀü ¸ð´ÏÅ͸µ À§¿øÈ¸(DSMB) °¨µ¶

        [¿ä±¸ »çÇ×]
        * °ü·Ã »ý¸í°úÇÐ ÇÐÀ§(¾àÇÐ, °£È£»ç, »ý¹°ÇÐ µî)
        * Á¦¾à »ê¾÷¿¡¼­ ÃÖ¼Ò 7³â ÀÌ»ó ±Ù¹«ÇÑ °æÇè(¾à¹° Áؼö Æ÷ÇÔ)
        * ICH(E2A-E2F), CIOMS, GVP ¹× US CFRÀ» Æ÷ÇÔÇÑ °­·ÂÇÑ ±ÔÁ¦ Áö½Ä
        * ³ôÀº ¼öÁØÀÇ ¾à¹° °¨½Ã Ȱµ¿ ÀÌÇØ
        * ÇØ´ç Ç¥ÁØ ¿î¿µ ÀýÂ÷¿¡ ´ëÇÑ ÀÌÇØ
        * ÄÄÇ»ÅÍ »ç¿ë ´É¼÷
        * ¿µ¾î ´É¼÷(¼­·ù ¹× ȸȭ)
        * CRO ±Ù¹« °æÇèÀÚ ¼±È£
        * º¸°í¼­(DSUR, PBRER, PSUR) ¹× RMP/RAMS ÀÛ¼º ¼±È£ °æÇè

        [ÇÊ¿ä ¿ª·®]
        * ¶Ù¾î³­ ´ëÀÎ °ü°è, ¾ð¾î ¹× ¼­¸é ÀÇ»ç¼ÒÅë ´É·Â
        * ¸®´õ½Ê ¹× ¶óÀÎ °ü¸® ±â¼ú
        * °­·ÂÇÑ ¿µÇâ·Â°ú Çù»ó ´É·Â
        * °èȹ ¹× Á¶Á÷ ±â¼ú
        * ÀÏÀÏ ÁöÇ¥ ¶Ç´Â ÆÀ ¸ñÇ¥¸¦ ÃæÁ·Çϱâ À§ÇÑ È¿°úÀûÀÎ ½Ã°£ °ü¸®
        * ÁÖµµ±ÇÀ» Àâ°í µ¶¸³ÀûÀ¸·Î ÀÏÇÒ ¼ö ÀÖ½À´Ï´Ù
        * »ó´ã ±â¼ú
        * ¸ðÈ£ÇÑ »óȲ¿¡¼­ ÀûÀýÇÑ °áÁ¤À» ³»¸®´Â ´É·Â

      • [ÀüÇü ÀýÂ÷]

        • ¼­·ùÀüÇü > 1Â÷¸éÁ¢ > Àμº°Ë»ç > 2Â÷¸éÁ¢ > ÃÖÁ¾ÇÕ°Ý

        •  

        [±Ù¹« Á¶°Ç]

        • Á¤±ÔÁ÷

        • ¼ö½À3°³¿ù(¼ö½À±â°£µ¿¾È ±Þ¿© 80%Áö±Þ)

        • Æ÷°ý ÀÓ±ÝÁ¦

        • ±Ù¹«Áö: ¼­¿ï °­³²±¸ ¼±Á¤¸ª¿ª ÀαÙ



      • Summary of Job Purpose
        • * Manage and conduct PV activities for product life cycle
        • * Conduct the activities for managing PV system and its quality system
        • * Conduct the activities for maintaining domestic and global licensing rights
        • * Communicate with Regulatory Authorities

      • Roles and Responsibilities
        • * Ensure the managing of ICSRs according to Standard Operating Procedures (SOPs) and project/program-specific safety plans.
        • * Approval of ICSR based on the results of quality/medical review
        • * Manage expedited and regular reporting to regulatory authorities
        • * Authoring and/or reviewing aggregate safety reports (DSUR, PSUR/PBRER), Risk Management Plans, report for Renewal Market Authorization
        • * Supervise of risk/signal management process
        • * Manage the literature search and approval the results
        • * Supervise PV training (PV team, company-wide, refresh, advanced etc.)
        • * Review and approval of training material, assessments, and courses
        • * Develop, revise and review the PV and other requested SOPs/SDs
        • * Supervise the PV system and its quality system
        • * Operate and reviewing safety data exchange agreements
        • * Supervise internal & external audit and inspection
        • * Operate and manage the process of post marketing surveillance and re-examination process
        • * Supervise risk minimization activities and additional PV activities
        • * Decide the PV scope in the clinical trial planning phase
        • * Conduct and/or manage PV activities according to SMP in the clinical trial  
        • * Review and approve safety management plan and investigator¡¯s brochure
        • * Supervise safety database (global safety database and ICSR tracker) / UAT
        • * Supervise data safety monitoring committees (DSMB)

      • Requirements; Education, Qualification and Experience
        • * Relevant life sciences degree (such as pharmacy, nurse, biology)
        • * Minimum 7 years of experience in Pharmaceutical industry including pharmacovigilance
        • * Strong regulatory knowledge including ICH(E2A-E2F), CIOMS, GVP and US CFR
        • * High level of understanding pharmacovigilance activities
        • * Understanding of corresponding Standard Operating Procedures
        • * Computer skills including use of computer, knowledge of Microsoft Word, Excel and PowerPoint preferred
        • * Competent in written and oral English
        • * Preferred work experience in CRO
        • * Preferred Experience writing Aggregate reports (DSUR, PBRER, PSUR) and RMP/RAMS

      • Competency 
        • * Excellent interpersonal, verbal and written communication skills
        • * Leadership and line management skills
        • * Strong influencing and negotiation skills
        • * Planning and organizational skills
        • * Effective time management in order to meet daily metrics or team objectives
        • * Able to take initiative and work independently
        • * Consultative skills
        • * Ability to make appropriate decisions in ambiguous situations

  • ¡¤ ÇìµåÇåÅÍ : ±èÈñ°­ / »ó¹«
  • ¡¤ ÀüÈ­¹øÈ£ : 02-759-9964
  • ¡¤ À̸ÞÀÏ : kimhgang@tbps.co.kr
  • ¡¤ »óÅ : ÁøÇàÁß